Greg is a member of the Strategy & Business Development organization of Sanofi. He and his team inform the R&D strategy and oversee the search & evaluation activities of Sanofi Genzyme Rare Diseases. His team’s work culminates with the launch of R&D collaborations and partnerships with academic research institutions, incubators and startups as well as biotech and pharma companies. Greg is based in California where Sanofi Genzyme Rare Diseases has established and brought to fruition numerous partnerships over the years. Prior to this role, Greg was the alliance manager of Sanofi’s strategic research alliances with Caltech, Scripps Genomic Medicine and Salk.
Greg is trained as a chemist and chemical engineer focused on applied research across chemical, material and biological sciences. He has hands-on experience in sales, marketing and business development with start-ups and global corporations. His prior entrepreneurial ventures involved bioinformatics, medical devices and therapeutics in dermatology, endocrinology, pulmonology and rheumatology.